USFDA APPLICATION NUMBER - 20884 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
aspirin(UNII: R16CO5Y76E) (aspirin - UNII:R16CO5Y76E) | aspirin | 25mg |
dipyridamole(UNII: 64ALC7F90C) (dipyridamole - UNII:64ALC7F90C) | dipyridamole | 200mg |
Inactive Ingredients
Ingredient Name | Teva Pharmaceuticals USA, Inc. |
---|---|
ACACIA(5C5403N26O) | |
ALUMINUM STEARATE(U6XF9NP8HM) | |
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
DIMETHICONE(92RU3N3Y1O) | |
FERRIC OXIDE RED(1K09F3G675) | |
FERRIC OXIDE YELLOW(EX438O2MRT) | |
GELATIN(2G86QN327L) | |
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)(8LDD2V82F5) | |
HYPROMELLOSES(3NXW29V3WO) | |
LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)(74G4R6TH13) | |
POVIDONE(FZ989GH94E) | |
SILICON DIOXIDE(ETJ7Z6XBU4) | |
STARCH, CORN(O8232NY3SJ) | |
STEARIC ACID(4ELV7Z65AP) | |
SUCROSE(C151H8M554) | |
TALC(7SEV7J4R1U) | |
TARTARIC ACID(W4888I119H) | |
TITANIUM DIOXIDE(15FIX9V2JP) | |
TRIACETIN(XHX3C3X673) |
LOOKING FOR A SUPPLIER?